Haleos Labs Limited (NSE:HALEOSLABS)
India
· Delayed Price · Currency is INR 1,278.40
+15.40 (1.22%)
At close: Mar 9, 2026
Haleos Labs Revenue
Haleos Labs had revenue of 947.83M INR in the quarter ending December 31, 2025, with 12.04% growth. This brings the company's revenue in the last twelve months to 3.48B, up 0.63% year-over-year. In the fiscal year ending March 31, 2025, Haleos Labs had annual revenue of 3.45B with 12.67% growth.
Revenue (ttm)
3.48B
Revenue Growth
+0.63%
P/S Ratio
1.11
Revenue / Employee
5.87M
Employees
592
Market Cap
3.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.45B | 387.65M | 12.67% |
| Mar 31, 2024 | 3.06B | -96.02M | -3.04% |
| Mar 31, 2023 | 3.16B | -345.11M | -9.86% |
| Mar 31, 2022 | 3.50B | 844.79M | 31.81% |
| Mar 31, 2021 | 2.66B | 48.11M | 1.84% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TAKE Solutions | -70.53M |
| Lyka Labs | 1.30B |
| Panacea Biotec | 6.06B |
| Dishman Carbogen Amcis | 27.97B |
| Zota Health Care | 4.73B |
| Supriya Lifescience | 7.35B |
| Blue Jet Healthcare | 10.53B |
| Concord Biotech | 11.59B |